Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Thierry Naas's publication output changed over time?
ScholarIQpublication output · 1996–2020
Output grew0% over the shown period — from 1 works in 1996 to 1 in 2020.
1
1
1
1
2
1
1
1
2
1
1996200020042008200920112012201620172020
What are the most-cited papers on Thierry Naas?
ScholarIQmost cited works
Global Spread of Carbapenemase-producing<i>Enterobacteriaceae</i>
Patrice Nordmann, Thierry Naas, Laurent Poirel
S189281586. 20112,352 CitationsOPEN ACCESS
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Patrice Nordmann, Gaëlle Cuzon, Thierry Naas
S23772524. 20091,587 Citations
High Frequency Retrotransposition in Cultured Mammalian Cells
John V. Moran, Susan E. Holmes, Thierry Naas, Ralph J. DeBerardinis, Jef D. Boeke, Haig H. Kazazian
S110447773. 19961,041 CitationsOPEN ACCESS
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
Rafael Cantón, Murat Akova, Yehuda Carmeli, Christian G. Giske, Y. Glupczynski, Marek Gniadkowski, David M. Livermore, Vivì Miriagou, Thierry Naas, Gian María Rossolini, Ørjan Samuelsen, Harald Seifert, Neil Woodford, Patrice Nordmann
S71414007. 2012883 CitationsOPEN ACCESS
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
Matteo Bassetti, Roger Echols, Yuko Matsunaga, Mari Ariyasu, Yohei Doi, Ricard Ferrer, Thomas P. Lodise, Thierry Naas, Yoshihito Niki, David L. Paterson, Simon Portsmouth, Julián Torre‐Cisneros, Kiichiro Toyoizumi, Richard G. Wunderink, Tsutae Den Nagata
S23772524. 2020810 Citations
Related on ScholarIQ
Inserm
Institution
Global Spread of Carbapenemase-producing<i>Enterobacteriaceae</i>
Paper
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Paper
High Frequency Retrotransposition in Cultured Mammalian Cells
Paper
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
Paper
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
Paper